Thomas W. Ross Sr., Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 5,000 shares at $14.73 ($74K) on 2016-12-14, disclosed to the SEC on 2016-12-16.
Open-market purchase of $74k VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| VRX | BUY | 2016-06-27 | $98K | — | Filing → |